Federal contract award
75FCMC24F0164
NEW AWARD EVALUATION OF THE CELL AND GENE THERAPY ACCESS MODEL 75FCMC19D0080/75FCMC24F0135
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | OFC OF ACQUISITION AND GRANTS MGMT |
| NAICS | 541720 — Research and Development in the Social Sciences and Humanities |
| PSC | AN42 — HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH |
| Parent award / vehicle | 75FCMC19D0080 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $6.4M |
| Current contract value | $6.4M |
| Potential contract value / ceiling | $15.5M |
| Start date | Aug 16, 2024 |
| Current end date | Aug 15, 2027 |
| Potential end date | Aug 15, 2032 |
| Latest award activity | Aug 27, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 27, 2026 | P00004 | $0 | EVALUATION OF THE CELL AND GENE THERAPY ACCESS MODEL |
| May 18, 2026 | P00003 | $0 | EVALUATION OF THE CELL AND GENE THERAPY ACCESS MODEL. INCORPORATE FAR 52.222-90 ADDRESSING DEI DISCRIMINATION BY FEDERAL CONTRACTORS (APRIL 2026) TO COMPLY WITH UPDATED FAR GUIDANCE IMPLEMENTING EXECUTIVE ORDER 14398. |
| May 27, 2025 | P00002 | $-1.5M | EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING::EOI BILATERAL MODIFICATION TO DESCOPE PER EXECUTIVE ORDER 14222, IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE: CGT EVAL |
| Dec 6, 2024 | P00001 | $0 | NEW AWARD EVALUATION OF THE CELL AND GENE THERAPY ACCESS MODEL 75FCMC19D0080/75FCMC24F0135 |
| Aug 15, 2024 | 0 | $7.9M | NEW AWARD EVALUATION OF THE CELL AND GENE THERAPY ACCESS MODEL 75FCMC19D0080/75FCMC24F0135 |
Estimated positioning window
Aug 15, 2031 – Feb 15, 2032
45/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 45/100. Available recorded signals: 40 points.
- Contract end 2032-08-15 (2121 days from calculation)
- +5 points
- 103 historical awards in this buyer and category group
- +15 points
- 5 recorded award transactions
- +10 points
- Latest award action: 2026-08-27
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.